Interview: German Diagnostics Industry Questions Wisdom Of Reducing Coronavirus Test Reimbursement
COVID-19 testing capacity remains a priority, but reimbursement issues have come back onto agenda for Germany IVD manufacturers
German reimbursement of COVID-19 confirmatory tests has been reduced by one third, a decision that has frustrated both the testing labs and the diagnostics manufacturers who jointly provided the basis of the system that kept the coronavirus to within manageable proportions nationally.
You may also be interested in...
Germany’s medtech industry fears that the European Commission has been too distracted by the pandemic and must now focus on the operational necessities of ensuring the forthcoming MDR system is fit to use.
Luck had a role in Germany’s coronavirus control success, health minister Jens Spahn has claimed, but the facts show that it is not as simple as that.
Germany’s authorities are back on guard against COVID-19 following renewed regional outbreaks. Diagnostics manufacturers will continue to play a strong part in bringing the pandemic substantially under control, a recent industry association virtual conference heard.